YH
About
YHLO specializes in the development and production of in-vitro diagnostic instruments and reagents. The company offers a broad range of instruments (based on Chemiluminescence, ELISA, Immunoblot, and Immunofluorescence methodologies) with patented technologies and outstanding features, as well as a comprehensive total solution with portfolios in fertility and reproductive health, diabetes, infectious diseases, autoimmune disorders and other novel assays on rare diseases analysis.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 615 investors are based in Shenzhen, Guangdong, China.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech biotech
- Location
- Shenzhen, China
Contact Information
Find more investors like YHLO
Search Investors